Highbridge Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-215,783
Closed -$11.2M 1179
2018
Q1
$11.2M Buy
215,783
+192,937
+845% +$10.4M 0.18% 131
2017
Q4
$1.23M Buy
+22,846
New +$1.27M 0.02% 499
2017
Q3
Sell
-524,000
Closed -$32M 1695
2017
Q2
$32M Buy
524,000
+90,233
+21% +$5.49M 0.48% 37
2017
Q1
$26.3M Buy
433,767
+426,326
+5,729% +$25.9M 0.38% 63
2016
Q4
$421K Buy
7,441
+1,991
+37% +$117K 0.01% 838
2016
Q3
$323K Buy
+5,450
New +$319K 0.01% 983
2016
Q2
Sell
-6,393
Closed -$323K 1615
2016
Q1
$323K Sell
6,393
-113,917
-95% -$5.58M 0.01% 1155
2015
Q4
$6.06M Buy
120,310
+59,840
+99% +$3.02M 0.09% 245
2015
Q3
$2.85M Buy
60,470
+43,912
+265% +$2.33M 0.04% 445
2015
Q2
$899K Sell
16,558
-31,021
-65% -$1.74M 0.01% 760
2015
Q1
$2.61M Buy
47,579
+3,563
+8% +$202K 0.04% 468
2014
Q4
$2.38M Buy
44,016
+26,514
+151% +$1.48M 0.03% 447
2014
Q3
$990K Buy
17,502
+8,384
+92% +$471K 0.01% 670
2014
Q2
$503K Buy
+9,118
New +$497K 0.01% 745
2013
Q4
Sell
-53,867
Closed -$2.45M 1234
2013
Q3
$2.45M Buy
53,867
+9,746
+22% +$445K 0.03% 471
2013
Q2
$1.96M Buy
+44,121
New +$1.97M 0.02% 500

Other funds holding MRK

Highbridge Capital Management's MRK Position: Q4 2018 in Review

Highbridge Capital Management sold out of Merck (MRK) in Q4 2018, closing a stake of 54,066 shares — an estimated $3.66M sold.

Highbridge Capital Management first reported a position in MRK in Q2 2013 and held it in 21 quarters. The position peaked at $68.9M in Q2 2015. 2,250 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

  • Highbridge Capital Management reported no remaining Merck position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 54,066 Merck shares in Q4 2018, an estimated $3.66M.
  • Highbridge Capital Management first reported a position in Merck in Q2 2013 and held it in 21 quarters.
  • Highbridge Capital Management's Merck position peaked at $68.9M in Q2 2015.
  • 2,250 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.